Epilepsy Center

234 Goodman Street, Cincinnati, Ohio 45219 | (866) 941-UCNI (8264)

RAMPART Seizure Medication Study Ending Enrollment

Monday, January 24, 2011
Contact: 
Katy Cosse
(513) 558-0207
Kathryn_Cosse@uc.edu

CINCINNATI—The University of Cincinnati (UC) Department of Emergency Medicine has completed its participation in the clinical research study "Rapid Anticonvulsant Medications Prior to Arrival Trial” (RAMPART). The national trial reached its enrollment target Friday, Jan. 14, and has stopped enrolling patients across the country.
 
UC began enrollment in RAMPART June 2009, working with fire/EMS departments in Cincinnati, Blue Ash, Forest Park and Green Township in Ohio, and in Florence and Independence in Kentucky. RAMPART was designed to study whether anti-seizure medications given as a shot in the muscle were just as effective as anti-seizure medications given by intravenous injection (IV), the current protocol.

Read more »

* * *

The UC Neuroscience Institute, a regional center of excellence, is dedicated to patient care, research, education, and the development of new treatments for stroke, brain and spinal tumors, epilepsy, traumatic brain and spinal injury, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, disorders of the senses (swallowing, voice, hearing, pain, taste and smell), and psychiatric conditions (bipolar disorder, schizophrenia, and depression).